Martha Mims, MD, PhD
Disclosures: Stocks or stock options, excluding diversified mutual funds-Biogen Idec-|Grant or research support-Incyte-|Stocks or stock options, excluding diversified mutual funds-Amgen Stock-|Grant or research support-Celgene-|Grant or research support-Denovo- - 06/06/2021

Dr. Martha Mims is Professor of Medicine and Chief of Hematology/Oncology at Baylor College of Medicine and Ben Taub Hospital/Smith Clinic where she treats patients with hematologic malignancies and solid tumors.  Dr. Mims is Associate Director for Clinical Research in the Dan L Duncan Cancer Center at Baylor and directs the Clinical Trials Support Unit.